American Journal on Addictions

Article	Citations
Issue Information	58
AAAP's Annual Meeting and Scientific Symposium	26
Stand against stigma	25
Self assessment ad (002)	24
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression	21
Call for Special Issue 2024	20
Issue Information	20
2024 Annual Meeting Posters	20
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States	19
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada	19
AAAP 36th Annual Meeting & Scientific Symposium Save the Date	18
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment	18
AAAP Stimulant Use Disorder PIP	14
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey	14
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances	13
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021	13
Gender differences in circumstances associated with cannabis use	13
Issue Information	12
Narcotics Anonymous members in recovery from methamphetamine use disorder	12
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort	12
AAAP Annual meeting ad	12
Emotional regulation in Gaming Disorder: A systematic review	10
Become a member of AAAP!	10
Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID‐19 pandemic era in China	10
Identifying factors associated with peer recovery coach interactions and successful outcomes for patients with opioid use disorder in Southern West Virginia	9

Call for Review Papers 2024	9
Correlates of optimism among patients in substance use disorder inpatient treatment	9
Cannabis use disorder and increased risk of arrhythmia‐related hospitalization in young adults	9
AM Registration Flyer	9
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?	8
Tobacco use and impulsivity in people with mental illness: A systematic review	8
Call for Review Papers 2024	8
Call for Special Issue Papers 2024	8
Synthetic cannabinoid use and the acquired preparedness model	8
Call for review papers 2021	8
Call for Special Issue Papers 2025	8
	7
Issue Information ‐ Editorial Board	7
Call for review papers 2022	7
Issue Information ‐ ToC	7
Preconference On‐Demand availability	7
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study	7
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study	6
AAAP Podcast EP	6
Issue Information	6
AAAP Call for Abstracts	6
AAAP AATT Preconference	6
Issue Information ‐ Editorial Board	6
AJA Annual Meeting 2023	6
AAAP annual meeting and pre‐conference courses	5
Exploring cannabis as a treatment for chronic pain in a rural Appalachian population	5
Stand Against Stigma	5
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates	5
Issue Information ‐ ToC	5
2023 Advanced Addiction Psychopharmacology Course	5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us	5
Extended‐release buprenorphine in pregnancy	5
Issue Information ‐ Editorial Board	5
AAAP's Performance in practice activities	5
AJA AM Save the Date 2023	4
Call for special issue 2023	4
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study	4
Addiction specialists' attitudes toward psychedelics: A National Survey	4
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs	4
Call for Symposium Abstracts	4
	4
2021 AJA Reviewer List	4
A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting	4
FREE Live Webinar Psychotherapy Series: CAMS Approach to Suicidal Risk ‐ David A. Jobes, PhD, ABPP (Aug 13, 2025)	4
Personality predicting relapse: A facet analysis of the NEO PI‐R	4
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States	4
2023 Addictions and Their Treatment Course	4
Sleep disturbance in clients attending a specialist addiction clinic	4
	4
Registration open – AAAP annual meeting and pre‐conference courses	4

Health care service utilization and drug overdose death: A national nested case–control registry study	4
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder	4
Call for Special Issue 2023	4
Cannabis Use Disorders Performance in Practice	4
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem	3
Become an AAAP Member	3
AAAP 2024 Self‐Assessment Exam Now Available	3
Stand Against Stigma	3
Mini‐Symposia I	3
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort	3
Save the Date ‐ Annual Meeting 2025	3
Psychotherapy Webinar Series AJA	3
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series	3
AAAP Membership benefits	3
AJA AM save the date 2023	3
Medical Update	3
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders	3
Gambling, tobacco use, and health among individuals in substance use disorder treatment	3
Issue Information ‐ Editorial Board	3
	3
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth	3
Call for Review Papers 2023	2
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain	2
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users	2
2025 Call for Symposium Abstracts	2
Addiction Psychiatry Advanced Psychotherapy Curriculum	2
ORN Advancing racial equity	2
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients	2
Call for special issue 2023	2
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study	2
Concurrent Paper Sessions	2
Trends in substance use disorder diagnoses among Veterans, 2009–2019	2
Paper sessions	2
Medication Management for Stimulant Use Disorder Webinar	2
Film & Media Workshop	2
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review	2
Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts	2
Daily cannabis use may cause cannabis‐induced hyperalgesia	2
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic	2
Issue Information ‐ Editorial Board	2
Drugs and bugs: Negative affect, psychostimulant use and withdrawal, and the microbiome	2
AAAP on‐demand educational activities	2
Cannabis Use PIP Ad	2
Call for review papers 2022	2
2024 Annual Meeting Posters	2
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem	2
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 2024	1
AAAP Membership	1
Call for special issue 2023	1
Call for special issue 2023	1
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use	1
Medical Update	1
AJA Annual Meeting 2024	1
33rd AAAP Annual Meeting and Scientific Symposium Recap	1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study	1
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate‐to‐severe alcohol use disorder	1
Educating the community about the opioid epidemic and medications for opioid use disorder	1
Issue Information ‐ ToC	1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics	1
2023 Advanced Addiction Psychopharmacology Course	1
Mini‐Symposia II	1
Conference Schedule	1
Issue Information	1
AAAP Pre‐Conference On‐Demand Course ‐ AATT & AAP	1
Program title youth substance use and addiction timely updates on a critical issue	1
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder	1
Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl	1
Opioid use disorder in the active service: Implications for intervention	1
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization	1
Addiction Psychiatry Advanced Psychotherapy Curriculum	1
PCSS exchange AJA Ad	1
Legalization of cannabis in Canada—Local media analysis	1
Symposium III	1
Symposium I	1
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center	1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting	1
Issue Information	1
32nd AAAP Annual meeting & scientific symposium recap	1
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex	1
Cannabis and the overdose crisis among US adolescents	1

Examining family member characteristics by treatment status of the relative with substance use problems	1
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students	1
AAAP ORN PIP ad	1
AJA Psychedelics	1
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis	1
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder	0
Motivational Interviewing PIP	0
Symposia, Medical Update, and Case Conference	0
Discrimination experiences and problematic alcohol and cannabis use in young adulthood	0
Call for review papers 2023	0
Call for Review Papers 2024	0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US	0
2024 Reviewer List	0
Issue Information	0
Stand against stigma	0
AAAP Psychotherapy Curriculum Series	0
Issue Information ‐ Editorial Board	0
Serum brain‐derived neurotrophic factor in relation to craving and duration of abstinence in patients with heroin dependence—A case‐control study	0
Issue Information ‐ ToC	0
Addiction Psychiatry Advanced Psychotherapy Session, September 11, 2024	0
Trajectories of prescription opioid and heroin use in adulthood	0
AAAP_Call for Review papers‐2024	0
Absorption of naloxone in patients prescribed buprenorphine‐naloxone	0
Travel Award AJA	0
Faith leaders’ perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health	0
Issue Information	0
AAAP Travel Awards Open	0
	0
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths	0
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial	0
CSAM 2021 scientific conference	0
FREE Online Self‐Assessment Exam: ORN StUD Performance in Practice (PIP)	0
An examination of cannabis use motives among couples with intimate partner violence and alcohol use disorder	0
Issue Information	0
Issue Information ‐ Editorial Board	0
Issue Information	0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder	0
2022 Self‐Assessment examination	0
	0
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?	0
2023 Reviewer List (n = 223)	0
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program	0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial	0
Issue Information	0
FREE Training & Mentoring: PCSS and ORN	0
	0
AAAP Performance and Practice (PIP) Resources	0
Issue Information	0
Estimating the effects of prenatal cannabis exposure on birth outcomes	0
Call for Special Issue 2022	0
Become a AAAP Member	0
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience	0
Film & Media Workshop	0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder	0
Symposium IV	0
AJA psychedelic Ad	0
PCSS is here to help!	0
AAAP Podcast	0
	0
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)	0
Factors associated with dual and polytobacco use among people in residential substance use disorder treatment	0
Call for special issue 2021	0
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O	0
AAAP podcast	0
Conference Schedule	0
Symposium II	0
Pain intensity in patients using extended‐release naltrexone or opioid agonists and its effect on extended‐release naltrexone treatment outcomes	0
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use	0
Call for review papers 2023	0
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan	0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?	0
Issue Information ‐ Editorial Board	0
Opioid use disorder and its association with self‐reported difficulties participating in social activities	0
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey	0
ORN Consultant Recruitment ‐ Join A National Public Health Alliance	0
Food insecurity risk and alcohol use disorder in US young adults: Findings from the National Longitudinal Study of Adolescent to Adult Health	0
CSAM‐SMCA 2022 Scientific conference and annual meeting	0
Issue Information	0
AAAP PIPS 2023	0
Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients	0
AAAP's Educational Offerings	0
Binge drinking and sexual risk behavior among US sexual and gender minority college students	0
Motives for prescription opioid use: The role of alexithymia and distress tolerance	0
Become a AAAP Member	0
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study	0
Become A AAAP Member!	0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019	0
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?	0
	0
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study	0
Registration Open Now: Virtual Courses on Addictions and Their Treatment (Sep 12–13, 2025) and Advanced Addiction Psychopharmacology (Sep 20–21, 2025)	0
Medical marijuana access and prolonged opioid use among adolescents and young adults	0
Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID‐19 pandemic	0
Is your AAAP membership expiring soon?	0
Psychotherapy Webinar Series AJA	0